<html>
<head>
    <meta name="GENERATOR" content="Microsoft Visual Studio 6.0">
    <title>Biological Use Authorization</title>
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/ORA1.css"> -->
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/Ora_BlueTables.css"> -->
    <link rel="stylesheet" type="text/css" href="/OrPortal/Forms/Compliance/IBC/IBC.css">
    <!-- Get Database Subroutines -->
    
    <!-- End Get Database Subroutines -->
    <!-- #XXXinclude virtual = "/appAsp/Include/StringUtilities.asp" -->
    
    <style>
.OriginalValuesBorder {
    border:3px solid orange;margin-top:5px;
}
.OriginalValuesTitle {
    color:orange;
    font-weight:bold;
}
.highlight {
    background-color:lightyellow; 
    border:1px solid orange;
    padding:2px;
}
.SemiHighlight {
    color:orange;
}
.warning {
    background-color:#FFE4C4; 
    border:1px solid orange;
    padding:2px;
}

th, .thBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-weight:bold;
	font-family:verdana;
}
td, .tdBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-family:verdana;
}

.THLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
	font-weight:bold;
}
.TDLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
}

.THLine2 {
	color:navy;
	background:white;
	font-size:8pt;
	font-weight:bold;
}
.TDLine2 {
	color:navy;
	background:white
	font-size:8pt;
}


.GlobalTd {
	background:white;
	color:navy;
	font-size:9pt;
}
.hdg1 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}
.xxxhdg2 {
	background:white;
	color:brown;
	font-size:11pt;
	font-weight:bold;
}
.hdg2 {
	background:navy;
	color:white;
	font-size:11pt;
	font-weight:bold;
	margin:1px;
	border-width:1px;
	border-color:white;
	padding:2px;
}
.hdg3 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}


</style>
    <script>window.status='ORA Production Database';</script>
</head>
<body>
    <form action method="POST" id="form1" name="form1">
        <!-- Outer Table -->
        <table width="650" cellpadding="2" cellspacting="0" border="1">
            <tr>
                <td class="GlobalTd">
                    <script>window.status='ORA Production Database';</script><table width="100%" cellpadding="0" cellspacing="0" border="0px"><tr>
<td>Protocol#: B-20180014-01 (Amendment)</td>
<td style="text-align:right;">
<input type="checkbox" name="Compare">Compare with Original&#160;<input type="submit" name="Refresh" value="Go">
</td>
</tr></table>
<br><br><div class="hdg1" align="center">University of California, Riverside<br>Institutional Biosafety Committee (IBC)<br>Application for Biological Use Authorization Registration</div>
<br><div class="hdg2">A. INVESTIGATOR DATA</div>
<table border="0" cellpadding="1" cellspacing="1" width="100%">
<tr>   <th class="THBlue">Principal Investigator</th>   <td class="TDBlue">Frances M Sladek</td>
<td rowspan="10">&#160;&#160;&#160;&#160;&#160;</td>   <th class="THBlue">Email</th>   <td class="TDBlue">sladek@ucr.edu</td>
</tr>
<tr>   <th class="THBlue">Department</th>   <td class="TDBlue">CNAS Dean</td>   <th class="THBlue">Phone</th>   <td class="TDBlue">(951) 827-7289</td>
</tr>
<tr>   <th class="THBlue">Project Start/End Date</th>   <td class="TDBlue">4/15/2009-4/15/2020</td>   <th class="THBlue">Fax</th>   <td class="TDBlue">(951) 827-5104</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Project Title:</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Nuclear Receptors in Physiology and Disease</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Related Funding Agency(ies) (add as many as apply, even if use of rDNA is identical for each project):</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">NIH</td>
</tr>
<tr><td colspan="5">&#160;</td></tr>
<tr>   <th class="THBlue" colspan="2">Additional Contact person and phone # (if not or in addition to the PI):</th>   <td class="TDBlue" colspan="2">Poonam Deol, 827-3246; 909-238-6174</td>
</tr>
</table>
<br><br><div class="hdg2">B. RESEARCH LOCATIONS</div>
<table border="1" width="100%" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue" width="15%">Building &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Room #  &#160;&#160;&#160;</th>   <th class="THBlue" width="55%">List any containment facilities or equipment (biosafety cabinets, etc.) and their last certification dates. &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Certification<br>Date</th>
</tr>
<tr>   <td class="TDBlue">Psychology Building&#160;&#160;&#160;</td>   <td class="TDBlue">Vivarium&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Spieth Hall&#160;&#160;&#160;</td>   <td class="TDBlue">Vivarium&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences Building  &#160;&#160;&#160;</td>   <td class="TDBlue">1225&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Noel Keen Hall&#160;&#160;&#160;</td>   <td class="TDBlue">2002 FACS room&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences Building   &#160;&#160;&#160;</td>   <td class="TDBlue">2229&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">  	Biological Sciences Building   &#160;&#160;&#160;</td>   <td class="TDBlue">2215&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences Building&#160;&#160;&#160;</td>   <td class="TDBlue">2220&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue"> 	Biological Sciences Building   &#160;&#160;&#160;</td>   <td class="TDBlue">2226&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue"> 	Biological Sciences Building   &#160;&#160;&#160;</td>   <td class="TDBlue">2231&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue"> 	Biological Sciences Building   &#160;&#160;&#160;</td>   <td class="TDBlue">2223&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue"> 	Biological Sciences Building   &#160;&#160;&#160;</td>   <td class="TDBlue">CR2200C&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences Building&#160;&#160;&#160;</td>   <td class="TDBlue">2227&#160;&#160;&#160;</td>   <td class="TDBlue"> 	Nuaire Class II type 2&#160;&#160;&#160;</td>   <td class="TDBlue">5/15/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Noel Keen Hall&#160;&#160;&#160;</td>   <td class="TDBlue">Stem Cell Core&#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety cabinets as oversee by Stem Cell Core.&#160;&#160;&#160;</td>   <td class="TDBlue">2/17/2012&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Biological Sciences Building&#160;&#160;&#160;</td>   <td class="TDBlue">2227&#160;&#160;&#160;</td>   <td class="TDBlue"> 	Forma Class II A/B3  (currently not using)&#160;&#160;&#160;</td>   <td class="TDBlue">3/28/2016&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">iological Sciences Building    	  	&#160;&#160;&#160;</td>   <td class="TDBlue">2205  &#160;&#160;&#160;</td>   <td class="TDBlue">Nuaire Class II type 2 &#160;&#160;&#160;</td>   <td class="TDBlue">5/15/2018&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4204A  TC FMS&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4205E TC viral shared&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4208D TC small&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1 &#160;&#160;&#160;</td>   <td class="TDBlue">4212A bacterial&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4212D Mol Biol&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4212B clean PCR&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4205A mouse prep&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4214 mouse prep&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4216 mouse prep&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4208 open lab&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4212 storage corridor&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4204 storage corridor&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1 &#160;&#160;&#160;</td>   <td class="TDBlue">4208C Histology&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4212E chem Media&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4213B dark room&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4208A cold room&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">CR4200 equipment corridor&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">CR4200B sm equip corridor&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4204E microscopy&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4204F TC shared&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRB1&#160;&#160;&#160;</td>   <td class="TDBlue">4229 Glasswash and autoclave&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">C. PRIOR APPROVAL STATUS</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Application Type</th>   <td width="50%" class="TDBlue">Modification</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, please list the number of the approved protocol</th>   <td class="TDBlue">20180014</td>
</tr>
<tr>   <th class="THBlue">Does this project involve human or animal subjects, or a positive disclosure of a conflict of interest (income, loans, or management role in funding source, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has this project been reviewed by any other UCR review boards?  If so, indicate the relevant protocol numbers and approval dates:</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">IRB (human subjects)</th>   <td class="TDBlue">09-119</td>
</tr>
<tr>   <th class="THBlue">IACUC (animal subjects)</th>   <td class="TDBlue">A20170020</td>
</tr>
<tr>   <th class="THBlue">Conflict of interest (provide approval date)</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does this project involve strains of plant or animal pathogens not originating in California?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, CDFA and APHIS permits may be required.  List the relevant permit numbers and dates covered:</th>
</tr>
<tr>   <th class="THBlue">CDFA</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">APHIS</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Do experiments involve releasing organisms containing rDNA into the environment?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has an application for this release been filed with a state or federal regulatory agency?	Agency and date filed:</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using  a "Select Agent" (<a href="http://www.cdc.gov/od/ohs/lrsat.htm">www.cdc.gov/od/ohs/lrsat.htm</a>)</th>   <td class="TDBlue">False</td>
</tr>
</table>
<br><br><div class="hdg2">DESCRIPTION OF PROJECT</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Provide a brief, non-technical description and purpose of the project.</th>
</tr>
<tr>   <td class="TDBlue">The long term goal of this project is to elucidate the molecular mechanism of tissue-specific gene expression. The immediate goals are to determine the mechanism of action of one critical liver-enriched transcription factor, hepatocyte nuclear factor 4a (HNF4a) and other nuclear receptors. Found primarily in the liver, kidney, intestine and pancreas, HNF4a is a highly conserved member of the superfamily of ligand-dependent transcription factors (nuclear receptors) that regulates many target genes essential to basic metabolism as well as xenobiotic and drug metabolism. HNF4a has  been linked to several human diseases including hemophilia, diabetes, atherosclerosis and cancer via regulation of hepatitis B viral genes and P450 (cyp) genes. HNF4a is also known to be an essential gene in organisms ranging from insect to man and to be essential for the adult liver phenotype. Despite the obvious importance of HNF4a, much remains to be elucidated about its mechanism of action. To address this, our lab studies various aspects of HNF4-related biology, including interacting proteins, post-translational modifications and responses to environmental signals, ligand and target genes. HNF4a is a member of the superfamily of ligand-dependent transcription factors (nuclear receptors). It interacts with several other receptors and regulates the expression of others.

 A related project in the lab deals with other nuclear receptors with which we define their DNA binding specificity and target genes. Those receptors are expressed in Cos7 cells and the proteins are extracted and analyzed. Mouse tissues and human cell lines expressing endogenous nuclear receptors are also used.
</td>
</tr>
<tr>   <th class="THBlue">What are the specific objectives of the work with biohazardous materials?</th>
</tr>
<tr>   <td class="TDBlue">To study the mechanism by which the liver-enriched transcription factor HNF4 regulates gene expression. We analyze lipophilic compounds such as fatty acids that bind HNF4, interacting proteins and phosphorylation of HNF4.We also identify the genes that are regulated by HNF4a and the proteins that regulate HNF4a function.

To accomplish this we routinely transfect HNF4 and other cDNAs in mammalian and/or insect cell lines and transform HNF4 and other cDNAs in bacteria for expression of protein. We use recombinant adenovirus and lentivirus to express nuclear receptors and other factors in cell lines that are difficult to transfect with plasmids.

We inject tumor cells into mice in order to elucidate mechanisms of tumorigenesis. Some of the cell lines we will be injecting will be stably transfected cells in which we are expressing various versions of HNF4 and the Src tyrosine kinase.

We will also be looking at the actions of other nuclear receptors by treating animals with their ligands (e.g., dexamethasone for glucocorticoid receptor)and examining changes in gene expression in relevant organs.</td>
</tr>
</table>
<br><br><div class="hdg2">Potentially Biohazadous Materials</div>Please indicate yes or no if the following biohazardous materials are used currently within your laboratory or are proposed with the next year.  Please check all that apply.<table width="100%" border="0" cellpadding="0" cellspacing="0">
<tr>   <th colspan="2"><span class="hdg3">Human or Animal Infectious Agents</span></th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Prions</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Plant Infectious Agents</span>
</th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Other</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Recombinant DNA</span>
</th>
</tr>
<tr>   <th class="THLine1">Recombinant DNA in any form.</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Intentional release to the environment</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Transgenic Plants</span>
</th>
</tr>
<tr>   <th class="THLine1">Plants</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Liverworts</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Mosses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Algae</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Animals</span>
</th>
</tr>
<tr>   <th class="THLine1">Animals that are potential reservoirs of zoonotic diseases<br>(primates, wild animals, etc.)</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Infectious or hazardous agents in animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Human or primate cells in animals</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Transgenic animals</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Invertebrates</span>
</th>
</tr>
<tr>   <th class="THLine1">Exotic Arthropods</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Nematodes</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Intentional release to the environment</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic Insects</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Human Stem Cells</span>
</th>
</tr>
<tr>   <th class="THLine1">Human Stem Cells</th>   <td class="TDLine1">False</td>
</tr>
</table>
<br><div class="hdg2">Human or Animal Infectious Agents</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Agents &#160;&#160;&#160;</th>   <th class="THBlue">Host of Range of Agent &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Adenovirus&#160;&#160;&#160;</td>   <td class="TDBlue">Human/primate&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">lentivirus&#160;&#160;&#160;</td>   <td class="TDBlue">mammalian cells&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Escherichia coli K12&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using the wild-type of the agent?</th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you using genetically modified infectious agents (rDNA, mutagenesis, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe the agent and any potential safety issues.</th>   <td class="TDBlue">For the adenovirus, we will use recombinant versions that are replication defective and that are widely used in laboratories in the U.S. and that are commercially available. Some of these may incorporate inducible expression systems such as with doxycycline. All have been disabled in terms of infectious properties. We will use in the adenovirus cDNAs for nuclear receptor family, other transcription factors, co-regulators, etc.  

For the lentiviral vectors we will use  self-inactivating (SIN) viruses such as Lentilox 3.7 (pLL3.7, available via ATCC, VRMC-39). This lentiviral system is REPLICATION INCOMPETENT. It is a third generation vector system developed by MIT (http://web.mit.edu/jacks-lab/protocols/pll37.htm). It consists of transfecting in 4 different plasmids in order to create the virus; after replication in the transfected cell, the virus self inactivates and cannot replicate in any other cell. 

In addition to cDNAs, we will also be expressing shRNAs to knock down gene ex</td>
</tr>
<tr>   <th class="THBlue">Do the experiments have the potential to increase the host range of the agent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the vector replication competent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you using fusion proteins or cell entry domains?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe any safety precautions you would recommend.</th>   <td class="TDBlue">We are using an epitope tag called VSV on the HNF4. The VSV tag contains 15 amino acids from the C-terminal end of the vesicular stomatitis virus glycoprotein; the VSV tag has no functional activity on its own and does not alter HNF4 function; rather it serves solely as an eptiope tag to distinguish the recombinant HNF4 from the endogenous HNF4 protein. Other standard epitope tags are also used such as Myc, Flag, His. All are very well characterized and standard in molecular biology research.</td>
</tr>
<tr>   <th class="THBlue">Are you using human or primate blood, blood products, cells, cell lines or tissues</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#147;yes,&#148; please describe the blood, blood products, cells, cell lines or tissue and detail how the sample will be worked with during experimentation. Please include vendor information such as the ATCC number if available.</th>   <td class="TDBlue">We will receive primary human tissue from colon and liver. We will form colonic crypts from the colonic mucosal scrapings and then fix the tissue and stain with antibodies for protein expression. Tissue samples may be extracted for protein and RNA.
We use several human cell lines, including HeLa (CCL-2), HepG2 (HB-8065), Hep3B (HB-8064), HEK 293 (CRL-1573) and 293T (CRL-11268); HT-29, SW640, SW480, RKO, Colo320, HCT116 (CCL-247), Caco2 (HTB-37 (all human colon cancer cell lines, no viral products), and human lung cancer and primary cells. We also use monkey COS-7 cells (CRL-1651). All cell lines are standard cell lines, are very well characterized and have been in use for a long time by many labs worldwide without any danger to public health.  We are also using immortalized human colonocotyes (HCEC-1CT, HCEC-2CT and HCEC-A1309 UTSW). They are non tumorigenic and have the capacity to differentiate. HCEC-A1309 are partially transformed.</td>
</tr>
</table>
<br><div class="hdg2">Recombinant DNA</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">General features of the DNA &#160;&#160;&#160;</th>   <th class="THBlue">Species from which DNA originated &#160;&#160;&#160;</th>   <th class="THBlue">Species to receive DNA, type of vector, and transformation method &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">HNF4 encodes a transcription factor in teh nuclear receptor superfamily&#160;&#160;&#160;</td>   <td class="TDBlue">rat&#160;&#160;&#160;</td>   <td class="TDBlue">Insect cells (SF21 and Tn5) via baculovirus infection&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">GFP, RFP and other fluorescent protein tags&#160;&#160;&#160;</td>   <td class="TDBlue">fluorescent proteins are from plants&#160;&#160;&#160;</td>   <td class="TDBlue">See cell lines in section 6&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">	GST-, His-, MBP- and other tagged fusion proteins of HNF4, other nuclear receptors, transcription factors (e.g., p53, TCFs, c-Myc, etc.) and co-regulators (p300, GRIP1, SMRT, Mediator, TBP, PGC1, etc&#160;&#160;&#160;</td>   <td class="TDBlue">human, mouse, rat&#160;&#160;&#160;</td>   <td class="TDBlue">E.coli K-12 BL21 cells via transformation   &#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">HNF4, other nuclear receptors and co-regulators&#160;&#160;&#160;</td>   <td class="TDBlue">human, mouse and rat&#160;&#160;&#160;</td>   <td class="TDBlue">human embryonic kidney cells (293, 293T), human hepatoblastoma/hepatocellular carcinoma cells (HepG2, Hep3B), colon cancer (HCT116, CaCo2, SW640, SW480, HT29,etc) transiently via adenovirus and lentiv&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">HNF4 and other nuclear receptors, transcription factors and co-regulators&#160;&#160;&#160;</td>   <td class="TDBlue">human,mouse, rat, Drosophila, Nemastella, Trichoplax adhaerens (early metazoan), Nematostella vectensis (sea anemone), Mnemiopsis leidyi  (type of jelly fish) and potentially other metazoan organisms&#160;&#160;&#160;</td>   <td class="TDBlue">SV40-transformed monkey kidney cells (COS-7), human embryonic kidney cells (293 and 293T cells), human hepatoblastoma/hepatocellular carcinoma cell lines (HepG2, Hep3B), human colon carcinoma cell lin&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Protein kinases (e.g., Src, PKC, AMPK, AMPK, etc.)&#160;&#160;&#160;</td>   <td class="TDBlue">human, mouse, rat&#160;&#160;&#160;</td>   <td class="TDBlue">	SV40-transformed monkey kidney cells (COS-7), human embryonic kidney cells (293 and 293T cells), human hepatoblastoma/hepatocellular carcinoma cell lines (HepG2, Hep3B), human colon carcinoma cell li&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">	Luciferase promoter constructs containing various native and heterologous promoter sequences driving the expression of luciferase; transfection control plasmid -- beta galactosidase driven by  viral &#160;&#160;&#160;</td>   <td class="TDBlue">luciferase from firefly; Renilla from sea pansy&#160;&#160;&#160;</td>   <td class="TDBlue">See human and other mammalian cell lines in section 6 &#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Transcription factors (e.g., p53, RXR, RAR, PPAR, Myc, LEF/TCF, etc.), Co-regulators (e.g., SMRT, p300, CBP, Mediator complex components, STAGA components, PGC1, TAF components,etc.), kinases (PKC, Sr&#160;&#160;&#160;</td>   <td class="TDBlue">Human, mouse, rat&#160;&#160;&#160;</td>   <td class="TDBlue">Human, mouse and primate cell lines described in Section 6&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Will cultures of any recombinant organisms listed above exceed a volume of 10 liters?  </th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If so, where will the cultures be grown?</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does your experiment involve the transfer of a drug resistance trait to any microorganism, plant, or insect that does not acquire that trait naturally?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards of the experiments, including whether acquiring such a trait would compromise the use of the drug in medicine or agriculture.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you expressing genes encoding toxins with LD 50 less that 10 ng/kg of body weight?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the toxic product and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using hosts or vectors of rDNA (excluding E. coli K-12) that are viable pathogens of animals, plants, or microbes?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using recombinant DNA molecules containing the partial genome of any eukaryotic (plant or animal) virus?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the molecules, including genetic maps and the fraction of virus genome present, and safety precautions.</th>   <td class="TDBlue">Aside from the recombinant adenovirus vector, we using short to very short nucleotide sequences from CMV promoter; SV40 promoter, replication origin and poly A region; VSV tag; HA tag. </td>
</tr>
<tr>   <th class="THBlue">Are your experiments likely to enhance the pathogenicity or extend the host range of a viral vector (e.g., introduction of novel control elements or a oncogene)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the hazards and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using genes involved in cell cycle control in animals (oncogene, tumor suppressor, cytokine, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the potential hazards.</th>   <td class="TDBlue">We do experiments with tumor suppressor wt and mutant p53. There are no potential hazards as p53 is rapidly degraded in normal cells and  typically arrests cell growth, not promote it. We also do experiments with oncogenic kinases such as PKC, Src, Abl, etc. in transfection systems. These have been used in many labs around the world and there is no risk associated from using them in transfection systems.</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, list your recommendations in section 5.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><div class="hdg2">Vertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">Animal &#160;&#160;&#160;</th>   <th class="THBlue">Infectious Agent &#160;&#160;&#160;</th>   <th class="THBlue">Route(s) of Shedding/Excretion of Infectious Agents &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Mouse&#160;&#160;&#160;</td>   <td class="TDBlue">none&#160;&#160;&#160;</td>   <td class="TDBlue">NA&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Mouse&#160;&#160;&#160;</td>   <td class="TDBlue">Human cancer cell lines&#160;&#160;&#160;</td>   <td class="TDBlue">Not shed&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Mouse&#160;&#160;&#160;</td>   <td class="TDBlue">bacteria&#160;&#160;&#160;</td>   <td class="TDBlue">feces&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using human or primate cells in animals?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you infecting animals with infectious agents?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">Human cancer cells injected into mice are not infectious.The tumors we have observed arising from those cells are very well contained and there is no evidence of metastasis.
The bacteria we are gavaging mice with are also non infectious. The bacteria we will use are those that we previously isolated from the mice in the vivarium (V3 in Psych or Spieth Hall). The bacteria will be shed into the feces, as are the endogenous bacteria. There are no health hazards and no special precautions needed.</td>
</tr>
<tr>   <th class="THBlue">Do the animals shed the infectious agents?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; how long will shedding of the infectious agent occur?</th>   <td class="TDBlue">see above</td>
</tr>
<tr>   <th class="THBlue">Are you using animals that have been caught in the wild?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are there potential zoonotic diseases associated with the animals?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><br><div class="hdg2">Define Controls</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" width="50%">Do you need special equipment, engineering safeguards or personal protective equipment to maintain containment of your experiments (hoods, negative pressure rooms, gloves, etc.) </th>   <td class="TDBlue" width="50%">True</td>
</tr>
<tr>   <th class="THBlue"> If &#8220;yes&#8221;, list your recommendations.</th>   <td class="TDBlue">We do the work with tissue culture in Biological Safety Cabinets. For routine tissue culture work we use disposable lab coats and gloves. For Adenovirus and lentivirus experiments we use gloves, goggles and disposable lab coats. We will disinfect all non metal equipment and instruments that come in contact with the adenovirus or lentivirus with a solution of 10% bleach or a pharmicidal reagent composed of quartenary benzylammonium compounds. For metal surfaces such as stainless steel hoods the pharmicidal reagent composed of quartenary benzylammonium compounds (available from Pharmacia) will be used. From the MSDS: "It offers a wider spectrum "percentage-kill-ratio" of enveloped and non-enveloped viruses, gram-
positive, gram-negative and acid-fast bacteria (as well as spore-forming bacteria) and is effective as well against as fungi (yeasts,
mildew, molds) and its spores. It prevents the growth and contamination of Mycoplasma spp. and is effective against a vast array of
viruses including HIV and Hepatitis B." UV irradiation for at least 20 minutes after each use of the hood will also be used. 

We will double bag all materials that are autoclaved and disinfect the exterior of the autoclaved bag with bleach before disposal. We will use a biosafety cabinet with a UV light.</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)? </th>   <td class="TDBlue">None required</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">BSL2</td>
</tr>
</table>
<br><div class="hdg2">Acknowledgement of Responsibilities</div>
<div class="tdBlue">For each of the elements below, please indicate if you will be following the UCR standard operating procedures and/or policies. If you indicate &#8220;yes&#8221; then you agree to and must follow the standard procedures and/or policies. If you answer &#8220;no,&#8221; please enter a brief description (in the space provided below the question) of the procedure you will follow and include a justification for deviating from the standard procedure and/or policy.</div>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Decontamination of biohazardous spills: I will used a 0.5 % sodium hypochlorite  (1:10 dilution of household bleach) to decontaminate equipment and work surfaces.  In locations where bleach would cause corrosion, I will decontaminate with an iodophor (e.g., Wescodyne).</th>   <td class="TDBlue" nowrap>True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue">We typically wipe down our hoods with alcohol (70-90% ethanol) and/or use a pharmacidal reagent containing quartenary benzylammonium compounds.</td>
</tr>
<tr>   <th class="THBlue">Storage: Biohazardous material will be clearly labeled with the universal biohazard symbol.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for bloodborne pathogens.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All injuries and accidental inoculation, ingestion or inhalation of biohazardous material will be reported immediately to the lab director or supervisor and EH&amp;S (827-2648).  Dial 911 immediately for any medical emergency.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally.  Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">I understand that UC Riverside may be required by law to release a copy of this application to the public.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I understand that failure to comply with the applicable regulations governing the use of biohazardous materials described above may result in suspension of the authorization and might jeopardize any funding supporting the activities described herein.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I attest that I will conduct the study identified above in the manner described.  If I decide to make any changes in the procedure or if any problems occur which involve risk or the possibility of risk to others, I will immediately report such occurances or contemplated changes to the UCR Institutional Biosafety Committee, Research and Economic Development, 200 University Office Building, ext 2-4809; IBC@ucr.edu.</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>______________________________</td>
<td>___________</td>
<td rowspan="2">&#160;&#160;&#160;&#160;</td>
<td>______________________________</td>
<td>___________</td>
</tr>
<tr>
<td>Principal Investigator</td>
<td>Date</td>
<td>Co-Investigator</td>
<td>Date</td>
</tr>
</table>
<br><em>Electronically signed and submitted to ORA on 3/8/2019 6:38:41 PM by <b>Frances Sladek</b></em><hr>IBC CERTIFICATION<div class="tdBlue">I certify that the Institutional Biosafety Committee has reviewed the proposed project.  In compliance with NIH guidelines and other specific NIH instructions, the project is (check one)<br><img src="/appAsp/images/CheckedBox.gif"> Approved as is.<br><img src="/appAsp/images/CheckBox.gif"> Approved with the following conditions:<br><br><br>
</div>
<table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>Level:	<img src="/appAsp/images/CheckBox.gif">BL1 &#160;&#160;<img src="/appAsp/images/CheckedBox.gif">BL2 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL3 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL4 &#160;&#160;</td>
<td>
<em>Electronically Signed by<br><u><b>Peter Atkinson</b></u></em> __________________________4/19/2019</td>
</tr>
<tr>
<td>&#160;</td>
<td>Chair-Institutional Biosafety Committee &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Date</td>
</tr>
</table>
                    <!-- End Outer Table -->
                </td>
            </tr>
        </table>
    </form>
</body>
</html>
